vs
Side-by-side financial comparison of Envela Corp (ELA) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Envela Corp is the larger business by last-quarter revenue ($80.5M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, Envela Corp posted the faster year-over-year revenue change (66.6% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-3.7M). Over the past eight quarters, Envela Corp's revenue compounded faster (42.1% CAGR vs 31.3%).
Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
ELA vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.5M | $75.5M |
| Net Profit | $6.0M | — |
| Gross Margin | 20.5% | 69.3% |
| Operating Margin | 9.4% | 22.7% |
| Net Margin | 7.4% | — |
| Revenue YoY | 66.6% | 27.7% |
| Net Profit YoY | 274.6% | — |
| EPS (diluted) | $0.22 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $80.5M | $75.5M | ||
| Q3 25 | $57.4M | $54.5M | ||
| Q2 25 | $54.9M | $52.4M | ||
| Q1 25 | $48.3M | $46.0M | ||
| Q4 24 | $48.3M | $59.1M | ||
| Q3 24 | $46.9M | $80.5M | ||
| Q2 24 | $45.3M | $47.1M | ||
| Q1 24 | $39.9M | $43.8M |
| Q4 25 | $6.0M | — | ||
| Q3 25 | $3.4M | $8.8M | ||
| Q2 25 | $2.8M | $5.9M | ||
| Q1 25 | $2.5M | $3.0M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.7M | $20.3M | ||
| Q2 24 | $1.6M | $-4.5M | ||
| Q1 24 | $1.9M | $-4.8M |
| Q4 25 | 20.5% | 69.3% | ||
| Q3 25 | 22.8% | 77.7% | ||
| Q2 25 | 22.6% | 76.5% | ||
| Q1 25 | 24.8% | 77.1% | ||
| Q4 24 | 23.1% | 76.4% | ||
| Q3 24 | 24.4% | 63.9% | ||
| Q2 24 | 25.1% | 77.4% | ||
| Q1 24 | 25.9% | 75.5% |
| Q4 25 | 9.4% | 22.7% | ||
| Q3 25 | 7.3% | 17.6% | ||
| Q2 25 | 5.9% | 12.7% | ||
| Q1 25 | 6.5% | 8.7% | ||
| Q4 24 | 3.9% | 22.6% | ||
| Q3 24 | 4.3% | 27.4% | ||
| Q2 24 | 4.2% | -4.6% | ||
| Q1 24 | 5.9% | -5.3% |
| Q4 25 | 7.4% | — | ||
| Q3 25 | 5.8% | 16.2% | ||
| Q2 25 | 5.0% | 11.2% | ||
| Q1 25 | 5.2% | 6.5% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 3.6% | 25.2% | ||
| Q2 24 | 3.5% | -9.6% | ||
| Q1 24 | 4.8% | -11.0% |
| Q4 25 | $0.22 | $0.26 | ||
| Q3 25 | $0.13 | $0.17 | ||
| Q2 25 | $0.11 | $0.12 | ||
| Q1 25 | $0.10 | $0.06 | ||
| Q4 24 | $0.07 | $0.40 | ||
| Q3 24 | $0.06 | $0.41 | ||
| Q2 24 | $0.06 | $-0.09 | ||
| Q1 24 | $0.07 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $9.9M | $22.7M |
| Stockholders' EquityBook value | $67.1M | $130.3M |
| Total Assets | $96.0M | $216.3M |
| Debt / EquityLower = less leverage | 0.15× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | $19.8M | $107.2M |
| Q4 25 | $9.9M | $22.7M | ||
| Q3 25 | $12.5M | $34.0M | ||
| Q2 25 | $13.0M | $45.3M | ||
| Q1 25 | $13.2M | $56.7M | ||
| Q4 24 | $13.5M | $68.0M | ||
| Q3 24 | $13.8M | $79.3M | ||
| Q2 24 | $14.3M | $90.7M | ||
| Q1 24 | $14.6M | $102.0M |
| Q4 25 | $67.1M | $130.3M | ||
| Q3 25 | $61.1M | $115.3M | ||
| Q2 25 | $57.8M | $104.7M | ||
| Q1 25 | $55.1M | $97.1M | ||
| Q4 24 | $52.7M | $92.1M | ||
| Q3 24 | $51.1M | $71.1M | ||
| Q2 24 | $50.2M | $48.5M | ||
| Q1 24 | $49.3M | $51.0M |
| Q4 25 | $96.0M | $216.3M | ||
| Q3 25 | $90.9M | $202.9M | ||
| Q2 25 | $82.7M | $194.9M | ||
| Q1 25 | $79.7M | $196.2M | ||
| Q4 24 | $77.9M | $213.3M | ||
| Q3 24 | $77.4M | $220.7M | ||
| Q2 24 | $73.8M | $205.0M | ||
| Q1 24 | $74.7M | $214.1M |
| Q4 25 | 0.15× | 0.17× | ||
| Q3 25 | 0.20× | 0.30× | ||
| Q2 25 | 0.23× | 0.43× | ||
| Q1 25 | 0.24× | 0.58× | ||
| Q4 24 | 0.26× | 0.74× | ||
| Q3 24 | 0.27× | 1.12× | ||
| Q2 24 | 0.29× | 1.87× | ||
| Q1 24 | 0.30× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $14.4M |
| Free Cash FlowOCF − Capex | $-3.7M | $14.4M |
| FCF MarginFCF / Revenue | -4.6% | 19.1% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $14.4M | ||
| Q3 25 | $2.4M | $9.7M | ||
| Q2 25 | $2.6M | $14.1M | ||
| Q1 25 | $1.1M | $3.6M | ||
| Q4 24 | $3.7M | $15.6M | ||
| Q3 24 | $3.4M | $11.0M | ||
| Q2 24 | $-789.5K | $1.0M | ||
| Q1 24 | $3.8M | $11.2M |
| Q4 25 | $-3.7M | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $2.1M | $14.1M | ||
| Q1 25 | $746.6K | $3.6M | ||
| Q4 24 | $3.2M | $15.6M | ||
| Q3 24 | $1.5M | $11.0M | ||
| Q2 24 | $-1.3M | $1.0M | ||
| Q1 24 | $3.3M | — |
| Q4 25 | -4.6% | 19.1% | ||
| Q3 25 | 3.8% | 17.7% | ||
| Q2 25 | 3.9% | 26.8% | ||
| Q1 25 | 1.5% | 7.7% | ||
| Q4 24 | 6.7% | 26.4% | ||
| Q3 24 | 3.1% | 13.7% | ||
| Q2 24 | -2.9% | 2.1% | ||
| Q1 24 | 8.4% | — |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 4.2% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
| Q4 25 | -0.59× | — | ||
| Q3 25 | 0.72× | 1.10× | ||
| Q2 25 | 0.94× | 2.41× | ||
| Q1 25 | 0.45× | 1.21× | ||
| Q4 24 | 2.34× | — | ||
| Q3 24 | 2.05× | 0.54× | ||
| Q2 24 | -0.50× | — | ||
| Q1 24 | 1.99× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELA
| Consumer Segment | $67.7M | 84% |
| Commercial Segment | $12.8M | 16% |
PBYI
Segment breakdown not available.
